Board of Directors

Stephen Thomas, PhD
Co-Founder and CEO,
Sera Medicines

Stephen is a Co-Founder of Navigator Medicines and current CEO of Sera Medicines, a biologics-focused accelerator advancing next-generation protein therapeutics to treat complex diseases with significant unmet medical needs.

Prior to Sera, Stephen led teams and strategy at Tenet Medicines (acquired by Eliem Therapeutics), ValenzaBio (acquired by Acelyrin), Cerecor (now Avalo Therapeutics) and Ichorion Therapeutics (acquired by Cerecor).

Stephen received his Ph.D. in Chemistry & Chemical Biology from Colombia University where he was also an NSF Predoctoral & BMS Graduate Fellow.